OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve
Siming Wang, Tamaki Ishima, Jiancheng Zhang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Brain–gut–microbiota axis in depression: A historical overview and future directions
Lijia Chang, Wei Yan, Kenji Hashimoto
Brain Research Bulletin (2022) Vol. 182, pp. 44-56
Open Access | Times Cited: 249

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 184

Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability
Lanxiang Liu, Haiyang Wang, Hanping Zhang, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 93

Brain-spleen axis in health and diseases: A review and future perspective
Wei Yan, Tong Wang, Lei Liao, et al.
Brain Research Bulletin (2022) Vol. 182, pp. 130-140
Open Access | Times Cited: 89

The gut microbiome and mental health: advances in research and emerging priorities
Andrew Shoubridge, Jocelyn M. Choo, Alyce M. Martin, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1908-1919
Closed Access | Times Cited: 82

Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 56

Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options
Akash Kumar, Jhilam Pramanik, Nandani Goyal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 565-565
Open Access | Times Cited: 50

Gut Microbiota Modulates Neurotransmitter and Gut-Brain Signaling
Shiyan Qu, Zijin Yu, Yaxuan Zhou, et al.
Microbiological Research (2024) Vol. 287, pp. 127858-127858
Closed Access | Times Cited: 22

The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota–Gut–Brain Axis: A Literature Review
Angela Dziedzic, Karina Maciak, Katarzyna Bliźniewska-Kowalska, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 1054-1054
Open Access | Times Cited: 17

Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics
A. Chen, Ying Gong, S. C. Wu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3

Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls
Cassandra E. Gheorghe, Nathaniel L. Ritz, Jason Martin, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 99

Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression
Yiyun Liu, Haiyang Wang, Siwen Gui, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 71

The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Benedetta Parodi, Nicole Kerlero de Rosbo
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69

Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation
Hui Yao, Dalin Zhang, Hao Yu, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 2, pp. 919-930
Open Access | Times Cited: 66

Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis
Chaoren Tan, Qiqi Yan, Yue Ma, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 59

Oral administration ofLactococcus lactisWHH2078 alleviates depressive and anxiety symptoms in mice with induced chronic stress
Kan Gao, Aitak Farzi, Xueqin Ke, et al.
Food & Function (2021) Vol. 13, Iss. 2, pp. 957-969
Closed Access | Times Cited: 57

(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis
Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105635-105635
Open Access | Times Cited: 54

Novel Pharmacological Approaches to the Treatment of Depression
Elias Elias, Ariel Y. Zhang, Melissa T. Manners
Life (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 48

Antibiotics and mental health: The good, the bad and the ugly
Katherine Dinan, Timothy G. Dinan
Journal of Internal Medicine (2022) Vol. 292, Iss. 6, pp. 858-869
Open Access | Times Cited: 47

Tryptophan metabolites in depression: Modulation by gut microbiota
Iva Lukić, Sanja Ivković, Miloš Mitić, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 43

A role of gut–microbiota–brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice
Yong Yang, Akifumi Eguchi, Xiayun Wan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110652-110652
Open Access | Times Cited: 40

The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Salvatore Chirumbolo, et al.
Pharmacological Research (2023) Vol. 192, pp. 106799-106799
Open Access | Times Cited: 40

Page 1 - Next Page

Scroll to top